Johnson Caroline, Baxter Bev, Brough Rodger, Buchanan John
Department of General Practice, University of Melbourne, Australia.
Aust Fam Physician. 2007 Apr;36(4):245-6.
The prescribing of benzodiazepines in the general practice setting raises many issues for general practitioners. In the latter part of 2005, GP members of The Royal Australian College of General Practitioners Victoria Faculty Drug and Alcohol Sub-Committee and GP-Psychiatry Liaison Sub-Committee met with representatives of the Royal Australian and New Zealand College of Psychiatrists and the Pharmacy Guild to discuss these challenges from their different perspectives.
This article aims to raise some issues about benzodiazepine prescribing that arose as part of an interprofessional dialogue between GPs, psychiatrists and pharmacists. This dialogue was an informal opportunity to debate current practice and learn from the perspective of others.
While a small group discussion has limitations in addressing all the issues pertaining to quality prescribing of benzodiazepines, it does provide a forum for useful debate and has the potential to enhance our effectiveness in the quality use of medicines, in the area of benzodiazepine prescribing.
在全科医疗环境中开具苯二氮䓬类药物给全科医生带来了诸多问题。2005年下半年,澳大利亚皇家全科医生学院维多利亚州分会药物与酒精小组委员会以及全科医生 - 精神病学联络小组委员会的全科医生成员与澳大利亚和新西兰皇家精神病学院及药剂师公会的代表会面,从各自不同角度讨论了这些挑战。
本文旨在提出一些关于苯二氮䓬类药物处方的问题,这些问题是全科医生、精神科医生和药剂师之间跨专业对话的一部分。这次对话是一个非正式的机会,用于辩论当前的做法并从他人的角度学习。
虽然小组讨论在解决与苯二氮䓬类药物高质量处方相关的所有问题方面存在局限性,但它确实提供了一个有益辩论的论坛,并且有可能提高我们在苯二氮䓬类药物处方领域合理用药的有效性。